(Current methods for measurement of arterial stiffness)Review articles

Mirela Rajčinova, David Zemánek, Lukáš Matera, Vratislav Fabián

Cor Vasa 2023, 65(3):525-528 | DOI: 10.33678/cor.2022.112  

Increased arterial stiffness is an independent risk factor for cardiovascular diseases. Measuring this parameter in clinical practice is controversial. Authors of this article bring review of current methods for measuring this parameter, but also for other haemodynamic parameters such as central aortic blood pressure and augmentation index. We discuss these topics and their pathophysiological context.

(Current role of mechanical thrombectomy in the treatment of acute ischemic stroke)Review articles

Jan Křeček, Boris Kožnar, Jakub Sulženko, Zdenko Stelmach, Petr Widimský, Ivana Štětkářová, Tomáš Peisker, Peter Vaško, Petr Mikulenka, David Lauer, Dušan Kučera

Cor Vasa 2023, 65(3):514-524 | DOI: 10.33678/cor.2022.105  

Ischemic stroke is a severe condition with a high mortality and a serious risk of permanent functional dis- ability. The treatment of acute ischemic stroke has undergone a number of major changes in recent years - from systemic thrombolysis to the wide range of current mechanical thrombectomy modalities. Studies such as MR CLEAN, ESCAPE, EXTEND-IA, SWIFT PRIME and others have demonstrated improved outcomes in patients with large vessel occlusion when mechanical thrombectomy was used compared with best medical treatment including systemic thrombolysis. These results have completely changed the treatment paradigm. Currently, a wide variety of endovascular...

Periprocedural myocardial injury after elective percutaneous coronary intervention in stable angina pectoris: a tertiary center experienceOriginal research articles

Mert Sarilar, Veysel Oktay, Gursu Demirci, Dogac Oksen, Vedat Sansoy

Cor Vasa 2023, 65(3):508-513 | DOI: 10.33678/cor.2022.111  

Background: Periprocedural myocardial injury and its clinical significance in stable patients are still under discussion. This subject has been assessed in many studies with different definitions, thresholds, and biomarkers for years. This study aimed to determine the clinical outcomes of periprocedural myocardial injury based on latest 4th UDMI guideline definitions. Methods: 238 patients who underwent elective percutaneous coronary intervention at single center were retrospectively enrolled. Patients who developed periprocedural myocardial injury were compared with patients with normal troponin values after the procedure for clinical outcomes. Primary...

The relationship between the level of soluble CD40 ligand and angiographic extent and severity of coronary artery diseaseOriginal research articles

Betül Cengiz Elçioğlu, Şükrü Taylan Şahin, Evin Bozçali, Şölen Himmetoğlu, Hüsniye Yüksel

Cor Vasa 2023, 65(3):501-507 | DOI: 10.33678/cor.2022.132  

Objectives: Previous studies have suggested that atherosclerosis is a chronic inflammatory disease and implicate components of the immune system in atherogenesis. The CD40 and CD40 ligand system regulates multiple phases of the humoral and cellular immune response. Soluble CD40 (sCD40) ligand especially releases from activated platelets. Platelets are involved not only in thrombosis, but also in atherosclerotic lesion formation and restenosis processes. The aim of our study is to evaluate whether there is a relationship between the level of sCD40 ligand and angiographic extent and severity of coronary artery disease (CAD) and to compare other cardiovascular...

Gender differences in epidemiology and risk factors of acute coronary syndrome in Algerian patients of the Oran city: descriptive cross-sectional studyOriginal research articles

Asma Amrani-Midoun, Nadia Laredj, Taki Djebaili, Abdelkader Djelloul, Lilia Zouli, Hamid Aoumeur, Farouk Boukerche, Mourad Nachi

Cor Vasa 2023, 65(3):496-500 | DOI: 10.33678/cor.2022.114  

Background and aims: The aim of this study is to determine the role of clinical, lifestyle, and behavioral characteristics on the severity of the disease according to the gender. Methods: We conducted a cross-sectional descriptive study. Results: An initial sample of 1219 patients was admitted for ACS in the cardiology service of Oran-University-Hospital-Center. The electrocardiographic results revealed that 34% of the patients had ST-segment elevation myocardial infarction (STEMI) while 66% had non-ST-segment elevation myocardial infarction (NSTEMI). In STEMI patients, the mean age was 60.87±12.20 years. STEMI patients sample included 413 patients...

Gut microbiota changes in nonalcoholic fatty liver disease and concomitant coronary artery diseaseOriginal research articles

Galyna Fadieienko, Oleksiy Gridnyev, Olena Kurinna, Nataliia Chereliuk

Cor Vasa 2023, 65(3):489-495 | DOI: 10.33678/cor.2022.126  

Background and the research aim: Nonalcoholic fatty liver disease (NAFLD) bears serious economic consequences for the health care system worldwide and Ukraine, in particular. Cardiovascular diseases (CVD) are the main cause of mortality in NAFLD patients. Changes in the gut microbiota composition can be regarded as a potential mechanism of CVD in NAFLD patients. The research aim was the investigation changes in major gut microbiota phylotypes, Bacteroidetes, Firmicutes, and Actinobacteria with quantification of Firmicutes/Bacteroidetes in NAFLD patients with concomitant CVD. Materials and methods: There were...

Impact of invasively determined cardiac power index on survival in patients with advanced chronic heart failureOriginal research articles

Ali Dogan, Denyan Mansuroglu, Oguz Konukoglu, Emrah Ozdemir, Mert Sarilar, Ayda Guler, Nuri Kurtoglu

Cor Vasa 2023, 65(3):485-488 | DOI: 10.33678/cor.2022.100  

Background: Hemodynamic parameters have recently emerged as tools for risk stratification of heart failure patients. Cardiac power output (CPO) is an indicator of cardiac performance. Cardiac power index (CPI) is calculated by indexing CPO to body surface area. The study aimed to demonstrate the prognostic role of resting CPI in advanced chronic heart failure patients. Methods: The study included patients with advanced chronic heart failure, ejection fraction below 30%, and classes III and IV functional capacity who had had right and left heart catheterization. A total of 99 patients were enrolled, with those having left ventricular assist device (LVAD)...

The Drugs Used in the Treatment of Supraventricular Tachycardia in Pediatrics: A Systematic Review and Meta-AnalysisOriginal research articles

Hashim Talib Hashim, Jaffer Shah, Ali Talib Hashim, Omar Abdelnasser Abdelmonem Ismail Mohamed, Mahmoud Shaban Abdeljalil, Joseph Varney

Cor Vasa 2023, 65(3):477-484 | DOI: 10.33678/cor.2022.097  

Background: Supraventricular tachycardia (SVT) is an abnormally rapid heart rhythm that results from improper electrical activity in the upper part of the heart. Acute management of children presenting with SVT may be a challenge, as the exact tachycardia mechanism is often unknown. The strategy for treatment depends on the presentation and clinical status of the patient. Methodology: A systematic literature review was conducted to identify and select original research reports on supraventricular tachycardia management drugs in children and infants with no structural heart disease (all children from 1 hour to 17 years of age) in accordance with the...

The clinical and angiographic impact of intravascular ultrasound guided stenting of unprotected left main and proximal left anterior descending coronary artery. A prospective randomized controlled study in EgyptOriginal research articles

Noha Hassanin Hanboly, Yasser Mohamed Kamel Baghdady, Mostafa Mokhtar Mostafa, Assem Abdelaziz Fahmy Hashad, Yasser Ahmed Sadek

Cor Vasa 2023, 65(3):468-476 | DOI: 10.33678/cor.2022.101  

Background: Coronary angiography has some limitations in the proper assessment of coronary artery le- sions. Intravascular ultrasound (IVUS) before percutaneous coronary intervention (PCI) can identify significant stenosis, select the appropriate stent and detect complications. The study aimed to evaluate the impact of intravascular ultrasound on clinical and angiographic outcomes after revascularization by stenting for patients with unprotected left main (ULM) or proximal left anterior descending (LAD) coronary artery disease (CAD). Materials and methods: A prospective randomized controlled study that was carried on sixty patients presented with stable...

The impact of the cardiovascular risk factors on short-term in-hospital outcome of patients with COVID-19Original research articles

Noha Hassanin Hanboly, Sameh Wadie, Reda Hussain Diab, Mohamed Omar

Cor Vasa 2023, 65(3):461-467 | DOI: 10.33678/cor.2022.095  

Background: Coronavirus disease (COVID-19) has caused significant morbidity and mortality. COVID-19 is more than a respiratory illness, it had multiple systemic effects such as myocarditis, arrhythmias, and venous thromboembolism. Aim of the study: We aimed to study the frequency of cardiovascular risk factors in patients with COVID-19 and the impact of these risk factors on short-term in-hospital outcome of patients newly discovered with COVID-19. Materials and methods: Cross-sectional analytic study conducted in Egypt on 200 patients (mean age of 44.2±12.7 years old) with positive polymerase chain reaction for COVID-19 recruited from different...

(Endovascular treatment of abdominal aortic aneurysm with angulated neck)Original research articles

Khaled El Samman, Petr Šedivý, Helena Přindišová, Alena Šnajdrová

Cor Vasa 2023, 65(3):455-459 | DOI: 10.33678/cor.2023.017  

Aim: To evaluate the technical and clinical success of stent graft implantation in abdominal aortic aneurysm (AAA) with neck angulated more than 60 degrees. Methods: We retrospectively analyzed the outcomes of endovascular treatment of subrenal aortic aneurysm (EVAR) performed from 2013 to 2021 in patients with AAA neck angulation greater than 60 degrees. The cohort consists of 27 patients with neck angulation of 65-95 degrees. Results: In all 27 cases the stent graft (SG) was correctly implanted by the same endovascular team. Type I endoleak was present in 2 patients. In the first case, we managed the endoleak with proximal SG exten- sion, in the...

(Implantation of leadless pacemaker (LP) Micra - single center experience)Original research articles

Jan Boček, Markéta Segeťová, Jan Beneš, Hanka Wünschová, Kamil Sedláček, Věra Lánská, Josef Kautzner

Cor Vasa 2023, 65(3):447-453 | DOI: 10.33678/cor.2022.104  

Introduction: Since beginning of cardiac pacing, implanters have been facing problems related to the weakest part of pacing system - pacing leads. Historically, there were problems with lead insulation or coating; another problem is lead or fixating helix fracture.^1,2 Infection of cardiac implantable electronic devices (CIEDs) is also a significant issue.^3,4 As a reaction to these challenges, the concept of leadless pacing was developed. In this stimulation modality, miniature pacemaker is implanted directly into cavity of right

Jiří Šedý: Kritické myšleníBook reviews

Prof. MUDr. Jan Petrášek, DrSc.

Cor Vasa 2023, 65(2):440  

Hana Skalická, Miloš Táborský a kolektiv: Ambulantní kardiologie v praxi Snadno a s přehledemBook reviews

Prof. MUDr. Michael Aschermann, DrSc.,

Cor Vasa 2023, 65(2):439  

(2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).Guidelines

Radek Pudil, Vilém Danzig, Jiří Veselý, Filip Málek, Miloš Táborský, Lubomír Elbl, Aleš Linhart, Hana Skalická

Cor Vasa 2023, 65(2):350-434 | DOI: 10.33678/cor.2023.032  

Translation of the shortened document prepared by the Czech Society of Cardiology)Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, Cutter DJ, de Azambuja E, de Boer RA, Dent SF, Farmakis D, Gevaert SA, Gorog DA, Herrmann J, Lenihan D, Moslehi J, Moura B, Salinger SS, Stephens R, Suter TM, Szmit S, Tamargo J, Thavendiranathan P, Tocchetti CG, van der Meer P, van der Pal HJH; ESC Scientific Document Group.

(2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery.)Guidelines

Hana Skalická, Miloš Táborský

Cor Vasa 2023, 65(2):287-349 | DOI: 10.33678/cor.2023.034  

Translation of the shortened document prepared by the Czech Society of Cardiology)Halvorsen S, Mehilli J, Cassese S, Hall TS, Abdelhamid M, Barbato E, De Hert S, de Laval I, Geisler T, Hinterbuchner L, Ibanez B, Lenarczyk R, Mansmann UR, McGreavy P, Mueller C, Muneretto C, Niessner A, Potpara TS, Ristić A, Sade LE, Schirmer H, Schüpke S, Sillesen H, Skulstad H, Torracca L, Tutarel O, Van Der Meer P, Wojakowski W, Zacharowski K; ESC Scientific Document Group.

(2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG).Guidelines

Pavel Jansa, David Ambrož, Michael Aschermann, Marián Felšöci, Martin Hutyra, Radek Pudil, Jaroslav Lindner

Cor Vasa 2023, 65(2):236-286 | DOI: 10.33678/cor.2023.033  

Translation of the shortened document prepared by the Czech Society of Cardiology)Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, Rådegran G, Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S; ESC/ERS Scientific Document Group.

(2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.)Guidelines

Petr Peichl, Alan Bulava, Ondřej Toman, Josef Kautzner

Cor Vasa 2023, 65(2):186-235 | DOI: 10.33678/cor.2023.023  

(Translation of the shortened document prepared by the Czech Society of Cardiology)Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, Charron P, Corrado D, Dagres N, de Chillou C, Eckardt L, Friede T, Haugaa KH, Hocini M, Lambiase PD, Marijon E, Merino JL, Peichl P, Priori SG, Reichlin T, Schulz-Menger J, Sticherling C, Tzeis S, Verstrael A, Volterrani M; ESC Scientific Document Group.

(Multisystem inflammatory syndrome in adults in cardiology intensive care unit, brief summary and case report)Review articles

Martin Vojtíšek, Nedal Omran, Tereza Špornová, Pavel Červinka

Cor Vasa 2023, 65(2):181-185 | DOI: 10.33678/cor.2022.120  

Background: As a part of world-wide spreading COVID-19 disease pandemic, a life-threatening syndrome affecting predominantly young adults was discovered. This entity usually occurs within 4 weeks after the onset of SARS-CoV-2 infection. The disease is often associated with several organ involvements, including the heart. This newly emerging unit is known as multisystem inflammatory syndrome in adults (MIS-A). Case presentation: We describe a case of a 29-year-old patient with MIS-A with predominant cardiac involvement. At admission the patient experienced fever and signs of acute left-sided heart failure, which was thought to be associated with recent...

Vyhlášení soutěže o nejlepší publikaci v roce 2023Informations

Michael Aschermann

Cor Vasa 2023, 65(1):6  

Czech Cardiovascular Research and Innovation Day 2022 - AbstractsAbstracts

Cor Vasa 2023, 65(1):141-172  

František Koukolík: DrbyBook reviews

Jan Petrášek

Cor Vasa 2023, 65(1):140  

Čestmír Číhalík: Kardiologie v průběhu stoletíBook reviews

Jan Petrášek

Cor Vasa 2023, 65(1):139  

Pan profesor MUDr. Jan Marek, Ph.D., FESC, slaví životní výročíPersonalia

Michael Aschermann

Cor Vasa 2023, 65(1):138  

Anomalous origin of the left circumflex artery from right sinus of Valsalva: a rare case but with great clinical relevanceCase reports

Cristina Poleggi, Davide Restelli, Alfredo Luongo, Federica Cocuzza, Francesca Campanella, Mennili Sara, Alessio Currò, Antonino Recupero, Michele Scarano

Cor Vasa 2023, 65(1):133-136 | DOI: 10.33678/cor.2022.063  

Anomalous origin of coronary artery (CA) is rare and does not generally lead to myocardial infarction. We report a case of a 61-year-old man presented with paroxysmal supraventricular tachycardia and atypical chest pain. After arrhythmia subsided, ECG showed T wave abnormalities and transient cardiac enzymes were found to be elevated. Coronary angiography demostrated an anomalous origin of the left circumflex artery (LCx) from the right sinus of Valsalva but no obstructive atherosclerotic coronary lesions. The possible relation between the congenital coronary anomaly and the clinical manifestations of the patient is discussed.

Beware of the Unexpected: Acute Coronary Thrombosis Following the Mildly Symptomatic COVID-19 Infection and Two Different Therapeutic OptionsCase reports

Murat Gul, Sinan Inci

Cor Vasa 2023, 65(1):129-132 | DOI: 10.33678/cor.2022.074  

COVID-19 infection was declared a pandemic in March 2020 and is responsible for high morbidity and mortality around the globe. Although the most common clinical presentation is respiratory, cardiac complications are common and create new challenges for healthcare. We discuss two mildly symptomatic outpatients with COVID-19 presenting with acute ST-elevation myocardial infarction (STEMI) and high coronary thrombus burden without atherosclerotic plaque. Our report describes two different therapeutic approaches that illustrate the challenges encountered in the management of disseminated coronary thrombosis in patients with STEMI and COVID-19. Clinicians...

(Cardiac tamponade as severe manifestation of angiosarcoma)Case reports

Daniel Baran, Tomáš Roubíček, Rostislav Polášek

Cor Vasa 2023, 65(1):125-128 | DOI: 10.33678/cor.2022.082  

Angiosarcoma of the heart is the most common primary malignant tumour of the heart. It is characterized by rapid and aggressive growth. It most commonly affects the right side of the heart. Cardiac imaging and histology are the most important tests leading to right diagnosis. The prognosis of angiosarcomas is very poor. The only potential curative intervention is a radical surgical resection. We describe a case of a 20-year-old man presenting with cardiac tamponade as a severe manifestation of angiosarcoma.

Post-myocardial infarction left ventricular intramyocardial dissecting hematomaCase reports

Adam Vejmělek, Petr Němec, Petr Fila

Cor Vasa 2023, 65(1):120-124 | DOI: 10.33678/cor.2022.089  

Background: Intramyocardial dissecting hematoma (IDH) is blood-filled cavitation in the cardiac wall that can occur as a complication of myocardial infarction, chest trauma, or percutaneous intervention. It can develop in the left ventricular free wall, the right ventricle, or the interventricular septum. Case report: The case report describes a patient with IDH as a rare complication of myocardial infarction. The patient was hospitalized for ongoing irritating cough three months after ST elevated myocardial infarction treated with percutaneous coronary intervention. The echocardiography showed the image of a pseudoaneu- rysm of the left ventricle....

Post‑infectious acute myocardial infarction following COVID‑19 infection in a young patientCase reports

Rodolfo Caminiti, Giampaolo Vetta, Antonio Parlavecchio, Michele Magnocavallo, Stefano Postorino, Scipione Carerj, Francesco Antonio Benedetto

Cor Vasa 2023, 65(1):116-119 | DOI: 10.33678/cor.2022.064  

It is now widely known that COVID-19 can also cause various extrapulmonary manifestations. Possible mechanisms of cardiovascular damage include direct myocardial damage due to hypercoagulability caused by systemic inflammation, which may also lead to destabilisation of coronary plaques. We present a case of a 30-year-old young man following asymptomatic COVID-19 infection, who was admit- ted to the emergency room of the Grande Ospedale Metropolitano di Reggio Calabria, Italy, with typical chest pain. The patient had no cardiovascular disease, cardiovascular risk factors including no family history of cardiovascular disease. Urgent coronary angiography...

Surgical management of ascending aorta pseudoaneurysm in a patient with COVID-19Case reports

Sandra Rečičárová, Peter Ivák, Jan Pirk

Cor Vasa 2023, 65(1):113-115 | DOI: 10.33678/cor.2022.060  

Pseudoaneurysm of the thoracic aorta is a rare condition associated with high mortality. We present a case of a patient who developed a huge pseudoaneurysm 10 years after the Bentall procedure and one aortocoronary bypass while simultaneously being COVID-19 positive. After treating pneumonia, the surgery was successfully performed with suturing two defects in the aortic conduit. It is a unique case report where the patient survived two life-threatening conditions.